ESCAVITE LQ- vitamin a palmitate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, d-, thiamine hydrochloride, riboflavin, niacin, pyridoxine hydrochloride, cyanocobalamin, ferric pyrophosphate, ferrous cysteine glycinate, and sodium fluoride liquid 
GM Pharmaceuticals, INC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

ESCAVITE LQ

Active ingredient for caries prophylaxis:

Each 1 mL contains 0.25 mg fluoride as sodium fluoride.

Description:

Prescription drug multi-vitamin with iron and fluoride 0.25 mg drops

Each 1.0 mL contains (mark on dropper)

Vitamin A1,500 IU
Vitamin C35 mg
Vitamin D400 IU
Vitamin E7.5 IU
Thiamine0.5 mg
Riboflavin0.6 mg
Niacin8 mg
Vitamin B60.4 mg
Vitamin B120.9 mcg
Iron6 mg
Fluoride0.25 mg

Other ingredients:

Ascorbic Acid (Vitamin C), Carrageenan, Cholecalciferol (Vitamin D3), Citric Acid, Cyanocobalamin (Vitamin B12), D-alpha-tocopheryl acetate (Vitamin E), Ferrous Glycine Cysteinate, Ferric Pyrophosphate, Glycerin, Niacin, Orange Flavor, Potassium Sorbate, Propylene Glycol, Purified Water, Pyridoxine Hydrochloride (Vitamin B6), Riboflavin (Vitamin B2), Thiamin Hydrochloride (Vitamin B1), Vitamin A Palmitate, and Sucralose.

CLINICAL PHARMACOLOGY:

It is well established that fluoridation of the water supply (1ppm fluoride) during the period of tooth development leads to a significant decrease in the incidence of dental caries. Hydroxyapatite is the principal crystal for all calcified tissue in the human body. The fluoride ion reacts with the hydroxyapatite in the tooth as it is formed to produce the more caries-resistant crystal, fluorapatite. Three stages of fluoride deposition in tooth enamel can be distinguished:1

1) Small amounts (reflecting the low levels of fluoride in tissue fluids) are incorporated into the enamel crystals while they are being formed.

2) After enamel has been laid down, fluoride deposition continues in the surface enamel. Diffusion of fluoride from the surface inward is apparently restricted.

3) After eruption, the surface enamel acquires fluoride from water, food, supplementary fluoride, and smaller amounts from saliva.

INDICATIONS AND USAGE:

Supplementation of the diet with nine essential vitamins and iron, and supplementation of the diet with fluoride for caries prophylaxis.

The American Academy of Pediatrics recommends that children up to age 16, in areas where drinking water contains less than optimal levels of fluoride, receive daily fluoride supplementation.2

Escavite® LQ Multi-vitamin with Iron and Fluoride 0.25 mg provides fluoride in drop form for infants and young children from 6 months to 3 years of age in areas where the drinking water contains less than 0.3 ppm of fluoride and for children ages 3-6 years in areas where the drinking water contains 0.3 through 0.6 ppm of fluoride.2,3

Each 1.0 ml supplies sodium fluoride (0.25 mg fluoride per 1 mL) plus nine essential vitamins and iron.

Escavite® LQ Multi-vitamin with Iron and Fluoride 0.25 mg supplies significant amounts of vitamins A,C,D,E, thiamin, riboflavin, niacin, vitamin B6, vitamin B12, and iron to supplement the diet, and to help assure the deficiencies of these nutrients will not develop. Thus, in a single easy-to-use preparation, infants and children obtain nine essential vitamins and iron, plus fluoride.

WARNINGS:

As in the case of all medications, keep out of reach of children.

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of the reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

PRECAUTIONS:

The suggested dose should not be exceeded since dental fluorosis may result from continued ingestion of large amounts of fluoride.

When prescribing Escavite® LQ Multi-vitamin with Iron and Fluoride 0.25 mg drops: 1) Determine the fluoride content of the drinking water from all major sources. 2) Make sure the child is not receiving significant amounts of fluoride from other sources such as medications and swallowed toothpaste. 3) Periodically check to make sure that the child does not develop significant dental fluorosis

Escavite® LQ Multi-vitamin with Iron and Fluoride 0.25 mg drops should be dispensed in the original plastic container, since contact with glass leads to instability and precipitation. (The amount of sodium fluoride in the 50-mL size is well below the maximum to be dispensed at one time according to recommendations of the American Dental Association.)

DRUG INTERACTIONS:

Do not eat or drink dairy products within one hour of fluoride administration. Incompatibility of fluoride with dairy foods has been reported due to formation of calcium fluoride which is poorly absorbed.

ADVERSE REACTIONS:

Allergic rash and other idiosyncrasies have been rarely reported. To report adverse side effects or to obtain product information, contact GM Pharmaceuticals, Inc. at 1-888-535-0305.

OVERDOSAGE:

Prolonged daily ingestion of excessive fluoride will result in varying degrees of Fluorosis.

DOSAGE AND ADMINISTRATION:

1 mL daily, or as prescribed. May be dropped directly into mouth with dropper, or mixed with fruit juice, cereal or other food.

HOW SUPPLIED:

Escavite® LQ Multi-vitamin with Iron and Fluoride 0.25 mg drops is an orange to dark orange liquid with an orange odor available in 50 mL bottles with accompanying calibrated dropper.

(NDC 58809-877-50)

STORAGE:

Store at 25°C (77°F); excursions permitted to 15° to 30°C (59-86°F). See USP Controlled Room Temperature. Protect from light and moisture. Close tightly after each use.

Shake Well. Use calibrated dropper.

KEEP OUT OF REACH OF CHILDREN.

Occasional deepening of color has no significant effect on vitamin potency.

While taking drops with iron, a slight darkening of the teeth may occur. Brushing will minimize this temporary condition.

After opening, store away from direct light.

Your doctor or dentist is the best source of counsel and guidance in your child’s fluoride supplementation.

REFERENCES

1. Brudevold F, McCann HG. Fluoride and caries control - Mechanism of action. In: Nizel AE, ed. The Science of Nutrition and Its Application in Clinical Dentistry. Philadelphia: WB Saunders Co.; 1966;331-347.

2. American Academy of Pediatrics, Committee on Nutrition: Fluoride Supplementation for Children: Interim Policy Recommendations. AAP News, February 1995, pg 18.

3. American Dental Association Council on Dental Therapeutics. New Fluoride Schedule Adopted. ADA News. May 16, 1994;12-14.

Manufactured for:

GM Pharmaceuticals, Inc., Arlington, TX 76015

Covered by U.S. Patent No. 7,341,708.

R021616-1.

PRINCIPAL DISPLAY PANEL - 50 mL Bottle Label

NDC 58809-877-50
ESCAVITE® LQ
PRESCRIPTION
MULTI-VITAMIN WITH IRON
AND FLUORIDE 0.25 mg
DROPS
Rx Only
50 mL (1.69 FL. OZ.)

PRINCIPAL DISPLAY PANEL - 50 mL Bottle Label
NDC 58809-877-50
ESCAVITE® LQ
PRESCRIPTION
MULTI-VITAMIN WITH IRON
AND FLUORIDE 0.25 mg
DROPS
Rx Only
50 mL (1.69 FL. OZ.)

ESCAVITE LQ 
vitamin a palmitate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, d-, thiamine hydrochloride, riboflavin, niacin, pyridoxine hydrochloride, cyanocobalamin, ferric pyrophosphate, ferrous cysteine glycinate, and sodium fluoride liquid
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:58809-877
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC) (VITAMIN A - UNII:81G40H8B0T) VITAMIN A1500 [iU]  in 1 mL
ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ASCORBIC ACID35 mg  in 1 mL
CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41) CHOLECALCIFEROL400 [iU]  in 1 mL
.ALPHA.-TOCOPHEROL ACETATE, D- (UNII: A7E6112E4N) (.ALPHA.-TOCOPHEROL, D- - UNII:N9PR3490H9) .ALPHA.-TOCOPHEROL, D-7.5 [iU]  in 1 mL
THIAMINE HYDROCHLORIDE (UNII: M572600E5P) (Thiamine ION - UNII:4ABT0J945J) THIAMINE HYDROCHLORIDE0.5 mg  in 1 mL
RIBOFLAVIN (UNII: TLM2976OFR) (RIBOFLAVIN - UNII:TLM2976OFR) RIBOFLAVIN0.6 mg  in 1 mL
NIACIN (UNII: 2679MF687A) (NIACIN - UNII:2679MF687A) NIACIN8 mg  in 1 mL
PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE HYDROCHLORIDE0.4 mg  in 1 mL
CYANOCOBALAMIN (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204) CYANOCOBALAMIN0.9 ug  in 1 mL
FERRIC PYROPHOSPHATE (UNII: QK8899250F) (FERRIC CATION - UNII:91O4LML611) FERRIC CATION5 mg  in 1 mL
FERROUS CYSTEINE GLYCINATE (UNII: 8B4OP7RK5N) (FERROUS CATION - UNII:GW89581OWR) FERROUS CATION1 mg  in 1 mL
SODIUM FLUORIDE (UNII: 8ZYQ1474W7) (FLUORIDE ION - UNII:Q80VPU408O) FLUORIDE ION0.25 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
CARRAGEENAN (UNII: 5C69YCD2YJ)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
GLYCERIN (UNII: PDC6A3C0OX)  
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
WATER (UNII: 059QF0KO0R)  
SUCRALOSE (UNII: 96K6UQ3ZD4)  
Product Characteristics
ColorORANGEScore    
ShapeSize
FlavorORANGEImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58809-877-501 in 1 CARTON08/20/201310/03/2018
150 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
UNAPPROVED DRUG OTHER08/20/201310/03/2018
Labeler - GM Pharmaceuticals, INC (793000860)

Revised: 11/2019
 
GM Pharmaceuticals, INC